Drug coverage for transplantation turns into political football: big business trumps patients

Clin J Am Soc Nephrol. 2010 May;5(5):746-7. doi: 10.2215/CJN.01630210. Epub 2010 May 6.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Drug Costs
  • Eligibility Determination / legislation & jurisprudence
  • Government Regulation*
  • Health Care Reform / economics
  • Health Care Reform / legislation & jurisprudence*
  • Health Care Sector / legislation & jurisprudence
  • Health Services Accessibility / economics
  • Health Services Accessibility / legislation & jurisprudence*
  • Humans
  • Immunosuppressive Agents / economics
  • Immunosuppressive Agents / therapeutic use*
  • Insurance Coverage / economics
  • Insurance Coverage / legislation & jurisprudence*
  • Insurance, Health, Reimbursement
  • Kidney Transplantation / economics
  • Kidney Transplantation / legislation & jurisprudence*
  • Medicare / economics
  • Medicare / legislation & jurisprudence*
  • Patient Rights / legislation & jurisprudence*
  • Renal Dialysis
  • Societies, Medical
  • United States

Substances

  • Immunosuppressive Agents